Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Datroway

(DA-troh-way)
A drug used to treat adults with breast cancer that cannot be removed by surgery or has spread to other parts of the body, has been treated with other therapies, and is hormone receptor positive (HR+) and HER2-negative. It is also being studied in the treatment of other types of cancer. Datroway contains a monoclonal antibody called datopotamab that binds to a protein called TROP2, which is found on some cancer cells. It also contains an anticancer drug called deruxtecan, which may help kill cancer cells. Datroway is a type of antibody-drug conjugate. Also called datopotamab deruxtecan.
More Information
Search NCI's Dictionary of Cancer Terms